Diversified Consumer Services
Company Overview of University of Minnesota
University of Minnesota is an educational institution that provides undergraduate and graduate programs. It offers courses in business administration, agriculture and life sciences, arts, medicine, engineering, mathematics, nursing and health sciences, and social services. University of Minnesota was founded in 1851 and is based in Minneapolis, Minnesota.
Minneapolis, MN 55455
Founded in 1851
Key Executives for University of Minnesota
President and Board of Regents
Vice President of Research
Vice President of Health Sciences and Dean of Medical School
Vice President for University Relations
Compensation as of Fiscal Year 2015.
University of Minnesota Key Developments
University of Minnesota Names Jessica Hellmann as Director of the Institute on the Environment, Effective August 31, 2015
Jul 1 15
Renowned environmental researcher, scholar and communicator Jessica Hellmann has been named the new director of the University of Minnesota's Institute on the Environment. Hellmann, who is currently on the faculty of the Department of Biological Sciences at the University of Notre Dame, will begin her tenure as director of the Institute on the Environment August 31, 2015. She also will join the University faculty as the Russell M. and Elizabeth M. Bennett Chair in Excellence in the Department of Ecology, Evolution and Behavior in the College of Biological Sciences. As director of the Institute on the Environment, Hellmann will provide strategic leadership for the Institute, an internationally recognized organization working to solve grand environmental challenges, while promoting interdisciplinary research, teaching and leadership across the university, engaging external partners and stakeholders.
PlasmaTech Biopharmaceuticals Announces License Agreement with University of Minnesota
Jun 17 15
PlasmaTech Biopharmaceuticals Inc. has licensed an adeno-associated virus (AAV) gene therapy and intellectual property (IP) from the University of Minnesota to treat patients with Fanconi anemia (FA) disorder and other rare blood diseases. US.
Cellectis Plant Sciences, Inc. Signs License Agreement with the University of Minnesota
Apr 16 15
Cellectis plant sciences Inc. has announced that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide rights to use the technology covered by the patent rights of the family WO/2014/144155 entitled "Engineering Plant Genomes Using CRISPR/Cas Systems". In addition to meganucleases and TALEN (TradeMark) technology, this approach for targeted modification of plant genomes was developed by the laboratory of Professor Dan Voytas in the University of Minnesota. The technology has demonstrated results in plant genome engineering and adds to Cellectis plant sciences Inc. strong intellectual property rights in the gene editing field, in addition to meganuclease and TALENTM technologies. Similarly to meganucleases, Zinc Fingers and TALEN (TradeMark), CRISPR technology enables a number of useful tools to target specific loci in a genome and/or modulate the expression of genes. The technology is based on novel sequence-specific nucleases that can be cheaply engineered to recognize any gene of interest in a genome. Application in plants, similarly to the other gene editing technologies, could enable the development of valuable crops.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|